Form 4: Twist Bioscience Corp Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp, sold 241 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.
Summary
- On March 6, 2025, Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, sold 241 shares of common stock.
- The sale was executed at a price of $40.913 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
- Following the transaction, Werner directly owns 51,434 shares of Twist Bioscience Corp.
- The sale was mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations.
Management Comments
- The sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a 'sell to cover' transaction and do not represent discretionary trades by the Reporting Person.
Industry Context
This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies.
Key Dates
| Date | Description |
|---|---|
| 03/06/2025 | Date of stock sale transaction |
| 03/10/2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.